Jean-Jacques Bienaimé
Chairman and CEO
CEO
Board Member
Chairman
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Biomarin Pharmaceutical Inc (BMRN) | Former CEO and Former Chairman of the Board | $1,479,423 | $21,976,020 |
| 2022 | Biomarin Pharmaceutical Inc (BMRN) | Former CEO and Former Chairman of the Board | $1,313,954 | $18,351,880 |
| 2021 | Biomarin Pharmaceutical Inc (BMRN) | Former CEO and Former Chairman of the Board | $1,260,000 | $18,262,538 |
| 2020 | Biomarin Pharmaceutical Inc (BMRN) | CEO | $1,298,846 | $18,146,399 |
| 2019 | Biomarin Pharmaceutical Inc (BMRN) | CEO | $1,200,385 | $18,405,856 |
| 2018 | Biomarin Pharmaceutical Inc (BMRN) | Chief Executive Officer | $1,149,423 | $15,627,893 |
| 2017 | Biomarin Pharmaceutical Inc (BMRN) | Chief Executive Officer | $1,094,423 | $15,916,985 |
Executive changes
Earnings-call appearances
-
Biomarin Pharmaceutical Inc Q3 FY2023 Earnings Call2023-11-01
Biomarin Pharmaceutical Inc (BMRN)
-
Biomarin Pharmaceutical Inc Q2 FY2023 Earnings Call2023-07-31
Biomarin Pharmaceutical Inc (BMRN)
-
Biomarin Pharmaceutical Inc Q1 FY2023 Earnings Call2023-04-26
Biomarin Pharmaceutical Inc (BMRN)
-
Biomarin Pharmaceutical Inc Q3 FY2020 Earnings Call2020-11-05
Biomarin Pharmaceutical Inc (BMRN)
-
Biomarin Pharmaceutical Inc Q2 FY2020 Earnings Call2020-08-04
Biomarin Pharmaceutical Inc (BMRN)
-
Biomarin Pharmaceutical Inc Q1 FY2020 Earnings Call2020-04-29
Biomarin Pharmaceutical Inc (BMRN)